Rob Knight, PhD

Dr. Rob Knight is Vice President of Research & Clinical Development at Cellese | AnteAGE, where he leads scientific strategy, clinical research, and innovation across regenerative aesthetics and biotechnology. With more than a decade of experience in extracellular vesicles, exosomes, stem cell biology, and regenerative medicine, he specializes in translating complex science into clinically validated technologies and commercially successful products.

Before joining Cellese, Dr. Knight conducted postdoctoral research at UCLA’s Stein Eye Institute, developing extracellular vesicle-based therapies for corneal scarring and inflammation. He earned his PhD in Stem Cell and Extracellular Vesicle Biology, MSc in Tissue Engineering, and BSc (Hons) in Biomedical Science from Cardiff University. He is also a PhD co-supervisor at the University of Melbourne.

An internationally invited speaker and published scientist, Dr. Knight is recognized for making emerging regenerative technologies accessible, evidence-based, and relevant to clinical practice.